Evidence map›Paper›PMID 39853603›Full record

ArticleMolecular biology reports2025

Two case reports of biliary stent infections by extensively drug-resistant Escherichia coli carrying bla

Abhi Mallick, Soma Sarkar, Dipankar Sarkar, Puranjay Saha, Surojit Das

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Abhi MallickDepartment of Biomedical Laboratory Science and Management, Vidyasagar University, Midnapore, West Bengal, 721102, India.
Soma SarkarDepartment of Microbiology, Infectious Diseases & Beleghata General Hospital, Kolkata, West Bengal, India.
Dipankar SarkarDepartment of Critical care medicine, Manipal Hospital, Salt Lake, Kolkata, West Bengal, India.
Puranjay SahaDepartment of Microbiology, Malda Medical College and Hospital, Malda, West Bengal, India.
Surojit DasDepartment of Biomedical Laboratory Science and Management, Vidyasagar University, Midnapore, West Bengal, 721102, India. esurojitdas@gmail.com.ORCID http://orcid.org/0000-0003-1299-2855

Funding

Indian Council of Medical Research AMR/Adhoc/ 241/2020-ECD-II
6 · The paper itself

Abstract

backgroundRising antimicrobial resistance (AMR) is an acute public health emergency impeding the clinical efficacy of surgical interventions. Biliary stent placement is one of the routine surgical procedures that rarely lead to infections that are empirically managed by broad-spectrum β-lactams and fluoroquinolones. Critical priority pathogens, such as carbapenem-resistant Escherichia coli challenge treatment outcomes and infection prevention. METHODS AND

resultsTwo carbapenem-resistant Escherichia coli isolates recovered from biliary stent-infected patients were investigated for drug resistance and molecular typing from a tertiary-care hospital in eastern India. The isolates were extensively drug-resistant (XDR) and remained susceptible to aminoglycosides, tigecycline, fosfomycin, or colistin. Carbapenemase bla

conclusionsThis is the first report of carbapenem-resistant Escherichia coli carrying bla

Indexed as

Anti-Bacterial Agentsbeta-LactamasesDrug Resistance, Multiple, BacterialEscherichia coliEscherichia coli InfectionsTertiary Care CentersCarbapenemsHumansIndiaMicrobial Sensitivity TestsStentsAnti-Bacterial Agentsbeta lactamase NDM-5, E colibeta-LactamasesCarbapenemsAntimicrobial resistanceBiliary stentsbla NDM-5Escherichia coliSequence type

Identifiers

PMID39853603

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.